
Keywords: نظارت بر دارودرمانی; cfDNA; cell-free DNA; CNI; copy number instability; ctDNA; circulating tumor cell-free DNA; ddPCR; droplet digital PCR; GcfDNA; graft-derived cell-free DNA; LC-MS/MS; liquid chromatography tandem mass spectrometry; MIC; minimum inhibitory concentration; N